541540 Stock Overview
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Solara Active Pharma Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹761.90 |
| 52 Week High | ₹850.05 |
| 52 Week Low | ₹317.00 |
| Beta | 1.17 |
| 11 Month Change | -5.89% |
| 3 Month Change | 9.32% |
| 1 Year Change | 127.30% |
| 33 Year Change | -26.57% |
| 5 Year Change | 71.79% |
| Change since IPO | 178.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 541540 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.2% | -1.8% | -1.8% |
| 1Y | 127.3% | 41.2% | 27.2% |
Return vs Industry: 541540 exceeded the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 541540 exceeded the Indian Market which returned 27% over the past year.
Price Volatility
| 541540 volatility | |
|---|---|
| 541540 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 541540 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 541540's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 2,156 | Poorvank Purohit | www.solara.co.in |
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support.
Solara Active Pharma Sciences Limited Fundamentals Summary
| 541540 fundamental statistics | |
|---|---|
| Market cap | ₹36.59b |
| Earnings (TTM) | -₹5.36b |
| Revenue (TTM) | ₹12.22b |
3.0x
P/S Ratio-6.8x
P/E RatioIs 541540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 541540 income statement (TTM) | |
|---|---|
| Revenue | ₹12.22b |
| Cost of Revenue | ₹8.07b |
| Gross Profit | ₹4.15b |
| Other Expenses | ₹9.51b |
| Earnings | -₹5.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -111.57 |
| Gross Margin | 33.97% |
| Net Profit Margin | -43.88% |
| Debt/Equity Ratio | 75.3% |
How did 541540 perform over the long term?
See historical performance and comparison